Author

Xuli Qi

Observed name: Qi, Xuli

Institution: Guangdong Pharmaceutical University

Observed institutions: Central South University, Guangdong Pharmaceutical University, Xiangya Hospital Central South University

ORCID: 0009-0006-9638-3393

Observed ORCID: 0009-0006-9638-3393

OpenAlex ID: A5013721858

UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications

2021 · Yingxue Gao, Yijun Liu, et al. · Cancer Letters · 69

USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis

2019 · Yuchong Peng, Youhong Liu, et al. · Journal of Experimental & Clinical Cancer Research · 56

AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer

2023 · Linglong Yin, Yubing Ye, et al. · Journal of Experimental & Clinical Cancer Research · 22

UHRF1 promotes spindle assembly and chromosome congression by catalyzing EG5 polyubiquitination

2023 · Xuli Qi, Youhong Liu, et al. · The Journal of Cell Biology · 19

PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability

2023 · Yuchong Peng, Youhong Liu, et al. · Cell Death Discovery · 14

SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability

2024 · Yuchong Peng, Xuli Qi, et al. · British Journal of Cancer · 13

Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation‐mediated CDC6 protein degradation

2022 · Tanggang Deng, Qianling Zhu, et al. · Molecular Carcinogenesis · 8

A mitochondrial outer membrane protein TOMM20 maintains protein stability of androgen receptor and regulates AR transcriptional activity in prostate cancer cells

2025 · Linglong Yin, Yi Dai, et al. · Oncogene · 6

Works count: 22

Citation count: 207

H-index: 7

I10-index: 6